Loading…
Reported covered position: ASST VP, B&D CONSULTING
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Access to Life-Saving Medicine Act
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Advocate for increased appropriations for the Center for Disease Control & Prevention and the National Institues of Health Provided comments on following bills: Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695)
Access to Life-Saving Medicine Act
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ARTHRITIS FOUNDATION via ARTHRITIS FOUNDATION
2008 · third_quarter · Q3
Advocated for the increased appropriations for the Center for Disease Control & Prevention and the National Institutes of Health and supported the following bills: H.R. 2638 S. 3230 Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695) Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R.1283)
Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R.1283) Advocated for the increased appropriations for the Center for Disease Control & Prevention and the National Institutes of Health and
Source: Senate LDA
Advocate for increased appropriations for the Center for Disease Control & Prevention and the National Institues of Health Provided comments on following bills: Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695)
Access to Life-Saving Medicine Act
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Advocated for the increased appropriations for the Center for Disease Control & Prevention and the National Institutes of Health and supported the following bills: H.R. 2638 S. 3230 Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695) Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R.1283)
Arthritis Prevention, Control, and Cure Act of 2008
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R.1283) Advocated for the increased appropriations for the Center for Disease Control & Prevention and the National Institutes of Health and
Arthritis Prevention, Control, and Cure Act of 2008
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Advocated for the increased appropriations for the Center for Disease Control & Prevention and the National Institutes of Health and supported the following bills: H.R. 2638 S. 3230 Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695) Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R.1283)
Arthritis Prevention, Control, and Cure Act of 2008
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R. 1283)
Arthritis Prevention, Control, and Cure Act of 2008
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R. 1283)
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Advocated for the increased appropriations for the Center for Disease Control & Prevention and the National Institutes of Health and supported the following bills: H.R. 2638 S. 3230 Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695) Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R.1283)
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Advocate for increased appropriations for the Center for Disease Control & Prevention and the National Institues of Health Provided comments on following bills: Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695)
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Advocate for increased appropriations for the Center for Disease Control & Prevention and the National Institues of Health Provided comments on following bills: Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695)
Advocated for the increased appropriations for the Center for Disease Control & Prevention and the National Institutes of Health and supported the following bills: H.R. 2638 S. 3230 Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695) Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R.1283)
Advocate for increased appropriations for the Center for Disease Control & Prevention and the National Institues of Health Provided comments on following bills: Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695)
Advocate for increased appropriations for the Center for Disease Control & Prevention and the National Institues of Health Provided comments on following bills: Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695)
Biologics Price Competition and Innovation Act of 2007
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Advocate for increased appropriations for the Center for Disease Control & Prevention and the National Institues of Health Provided comments on following bills: Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695)
Biologics Price Competition and Innovation Act of 2007
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Advocate for increased appropriations for the Center for Disease Control & Prevention and the National Institues of Health Provided comments on following bills: Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695)
Biologics Price Competition and Innovation Act of 2007
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Advocated for the increased appropriations for the Center for Disease Control & Prevention and the National Institutes of Health and supported the following bills: H.R. 2638 S. 3230 Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695) Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R.1283)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Advocated for the increased appropriations for the Center for Disease Control & Prevention and the National Institutes of Health and supported the following bills: H.R. 2638 S. 3230 Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695) Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R.1283)
Arthritis Prevention, Control, and Cure Act of 2007
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R. 1283)
Arthritis Prevention, Control, and Cure Act of 2007
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Advocated for the increased appropriations for the Center for Disease Control & Prevention and the National Institutes of Health and supported the following bills: H.R. 2638 S. 3230 Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695) Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R.1283)
Arthritis Prevention, Control, and Cure Act of 2007
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R. 1283)
Arthritis Prevention, Control, and Cure Act of 2007
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R.1283) Advocated for the increased appropriations for the Center for Disease Control & Prevention and the National Institutes of Health and
Small Business Expensing Permanency Act of 2003
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Advocated for the increased appropriations for the Center for Disease Control & Prevention and the National Institutes of Health and supported the following bills: H.R. 2638 S. 3230 Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695) Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R.1283)
Arthritis Prevention, Control, and Cure Act of 2008
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/HR.1283)
Arthritis Prevention, Control, and Cure Act of 2007
Client: ARTHRITIS FOUNDATION · Firm: ARTHRITIS FOUNDATION
Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/HR.1283)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ARTHRITIS FOUNDATION via ARTHRITIS FOUNDATION
2008 · second_quarter · Q2
Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R. 1283)
Advocate for increased appropriations for the Center for Disease Control & Prevention and the National Institues of Health Provided comments on following bills: Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695)
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ARTHRITIS FOUNDATION via ARTHRITIS FOUNDATION
2008 · first_quarter · Q1
Advocate for increased appropriations for the Center for Disease Control & Prevention and the National Institues of Health Provided comments on following bills: Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695)
Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R. 1283)
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ARTHRITIS FOUNDATION via ARTHRITIS FOUNDATION
2007 · year_end · YY
Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/HR.1283)
Advocates for increased funding for the Center for Disease Control & Prevention and the National Institutes of Health;
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE